Globe Newswire The addition of miRNA and metadata to Aspira's existing protein assay shows promising improvements in both sensitivity and specificity for early-stage ovarian cancer in women with an adnexal...\n more…
Ticker Report StockNews.com downgraded shares of Aspira Women's Health (NASDAQ:AWH - Free Report) from a hold rating to a sell rating in a report released on Friday. Separately, Alliance Global Partners cut their...\n more…
Globe Newswire AUSTIN, Texas, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ( Aspira ) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic...\n more…
Globe Newswire Spoke designation acknowledges Aspira's position as an innovator in women's health, and provides new opportunities for funding, thought leadership and networking with other healthcare industry...\n more…